NSE filing, NSE: NIVABUPA. Summary written from the filing by ALFA Finder's alert engine.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹72.86
- Market cap
- ₹13,477 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 37.4×Sector 19.7×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half-year ended September 30, 2026. The trading window stays closed until November 6, 2026.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance announced the sad demise of Non-Executive Director Mr. Roger William John Davis, effective October 17, 2026.
Niva Bupa Health Insurance Company Credit Rating
Niva Bupa Health Insurance received a credit rating of IND AAA/Stable for its proposed subordinated debt issuance. This rating reflects the company's proposed debt instrument.
Niva Bupa Health Insurance Company Debt & Borrowing: ₹150 Cr
Niva Bupa Health Insurance will exercise its call option to redeem 1,500 non-convertible debentures on November 15, 2026, for a total principal amount of ₹150 Crore.
- Value
- ₹150.0 Cr
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa Health Insurance will hold a committee meeting on 09-Oct-2026 to consider altering the payment date for interest or redemption amounts on debt securities.
Niva Bupa Health Insurance Company Debt & Borrowing: ₹150 Cr
Niva Bupa Health Insurance will hold a Debt Raising Committee meeting on October 9, 2026, to approve the redemption of NCDs aggregating to ₹150 Crore.
- Value
- ₹150.0 Cr
Other management change announcements
All →Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.
Fabtech Technologies Management Change
FABTECH Technologies appointed Mr. Alan Dias as Vice President - HR, a senior management personnel role, effective October 28, 2026. He brings over 24 years of human resources experience.
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Sagarsoft (India) Management Change
Sagarsoft (India) appointed Ms. Arcot Ganeshan Monisha as Company Secretary and Compliance Officer, designated as KMP, effective 28 October 2026. Details are provided per Regulation 30 in the annexure.
Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Aeroflex Industries Management Change
Aeroflex Industries reports Drashti Bhil's change from Deputy CFO to CFO, plus Mustafa Kachwala's tenure completion as CFO effective 27 November 2026. Management reshuffle with no money or business event.